Seed Grants (USA epilepsy)
The Seed Grants from the American Epilepsy Society (AES) facilitate established investigators to pursue new and innovative lines of research, collaborations, and/or research methods. The
Research funding for medical-related challenges.
The Seed Grants from the American Epilepsy Society (AES) facilitate established investigators to pursue new and innovative lines of research, collaborations, and/or research methods. The
The Junior Investigator Global ATTR Amyloidosis Research ASPIRE from Pfizer supports early-career principal investigators worldwide (except for the USA) working on ATTR Amyloidosis. The grant
The Research and Training Workshops grants from the American Epilepsy Society (AES) support scientific conferences and workshops focused on epilepsy research and training. Proposed conferences
The Doctoral Training Fellowship provided by The Dunhill Medical Trust and the British Geriatrics Society support UK-based healthcare professionals, including doctors, nurses and allied health
The Infrastructure Grant from the American Epilepsy Society (AES) facilitates the creation of national or international multicenter research programs. Proposals are welcomed across the spectrum
The 3rd and 4th year Clinical Fellowship from the Cystic Fibrosis Foundation supports (adult and pediatric) physicians who have completed at least two years of
The 5th year Clinical Fellowship from the Cystic Fibrosis Foundation supports (adult and pediatric) physicians who have completed at least 4 years of fellowship training
The Clinical Study Grants from the British Heart Foundation provide research funding for interventional clinical trials and observational studies of specific patient groups. Funded studies
The 1st and 2nd year Clinical Fellowship from the Cystic Fibrosis Foundation supports first and second year clinical fellows to pursue training in cystic fibrosis-relevant
The Drug Development RFP from the Alzheimer´s Drug Discovery Foundation provides funding for investigational new drug (IND)-enabling studies (or the international equivalent) and early-phase clinical trials that
You can unsubscribe at any time.